stars 1 stars 2 stars 3

At SSI Strategy, we're strategic partners deeply invested in our clients' success. We offer a unique, adaptive approach to supporting biotech companies, integrating business acumen with deep expertise in Clinical Development & Operations, Regulatory affairs, Pharmacovigilance, Medical Affairs, Quality and more. Our agile skills and resources model allows us to adapt to your specific needs, working as an embedded team within your organization. We complement your existing teams, scaling specialized skill sets up and down as needed, while equipping them with the tools and resources to operate at peak performance. By fostering the organization you want to build, we position your full-time employees to be more successful and effective in their strengths. As your needs evolve, so does our support. We offer deep expertise, strategic insight, and a comprehensive range of services to help you navigate the challenges of bringing a therapeutic from concept to commercialization. Our mission is clear: Build better biotechs through seamless collaboration, informed decision-making, and accelerated progress.

SSI Strategy Questions

The SSI Strategy annual revenue was $6 million in 2026.

Douglas Locke is the CEO of SSI Strategy.

144 people are employed at SSI Strategy.

SSI Strategy is based in Parsippany, New Jersey.

Top SSI Strategy Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users